Coulter Partners places David Hastings as CFO at Trevi Therapeutics

Health, science and technology innovation business recruiter Coulter Partners has successfully led a search assignment for Trevi Therapeutics, Inc., placingDavid Hastings as Chief Financial Officer (CFO).

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC).

David Hastings brings over 25 years of financial leadership in the public life sciences and biopharmaceutical sectors to Trevi. His expertise spans capital raising, commercialization, and investor relations, having secured over $2 billion in equity and debt financing throughout his career. Most recently, Mr. Hastings served as CFO at Arbutus. He previously spent over a decade as CFO and Executive Vice President at Incyte, where he managed the company’s transition from R&D to commercialization following the launch of Jakafi®. During his tenure, he scaled the organization to over 700 employees and co-led major out-licensing deals. Mr. Hastings has also held CFO roles at Unilife and ArQule Inc. and currently chairs the Audit Committee for Scynexis, Inc.

Jennifer Good, President and CEO of Trevi Therapeutics, said:

I am thrilled to welcome Dave to the leadership team as we enter an important chapter of growth at Trevi. His proven track record and experience as we transition into Phase 3 development and beyond will be critical as we continue to advance Haduvio for the treatment of chronic cough. Filling this critical role required a search partner that could balance a thorough, robust process with a real sense of urgency, and Coulter Partners delivered on both counts. From the very beginning, the Coulter team demonstrated a deep understanding of our specific requirements and the Trevi culture. They worked in close partnership with us, leveraging their extensive network and assessment expertise to provide invaluable insights on prospective candidates. Ultimately, we relied on their trusted advice to identify the right fit for our team, and we are thrilled to welcome a leader of Dave’s caliber to Trevi.